Skip to main content

Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Wednesday, September 14, 2022
  • 9:00 AM – 9:55 AM
    Managing Limited Psoriasis with Topicals: It's All About Adherence to the Treatment
  • 10:10 AM – 11:10 AM
    Innovation Theater (non-accredited): Challenging AD Expectations: A Therapy Option That Challenges Treatment Goals for Patients With Refractory, Moderate to Severe Atopic Dermatitis (AD) Who Are Not Adequately Controlled With Other Systemic Drug Products
  • 11:25 AM – 12:10 PM
    Optimal Management of Moderate to Severe Psoriasis with Interleukin Inhibitors
  • 12:25 PM – 1:25 PM
    Innovation Theater (non-accredited): Step into Possibility - Discover Olumiant: the first and only FDA approved treatment for adults with Severe Alopecia Areata (AA)
  • 1:40 PM – 2:10 PM
    Ask the Experts: Pearls for Using Laser to Treat Vascular Birthmarks
  • 2:25 PM – 3:10 PM
    The Role and Utility of Novel Topical PDE-4 Inhibitors in the Management of Plaque Psoriasis, Atopic Dermatitis, and Seborrheic Dermatitis
  • 3:25 PM – 4:25 PM
    Innovation Theater (non-accredited): The Impact of IL-13 Inhibition as a Treatment Option for Adult Patients with Moderate-to-Severe Atopic Dermatitis
  • 4:40 PM – 5:10 PM
    Ask the Experts: Itch
  • 5:25 PM – 6:10 PM
    Contact Dermatitis Update
  • 6:25 PM – 7:25 PM
    Challenging Cases in Dermatology